Marijuana Company Tilray Posted ‘Mixed’ Results. Here’s What Wall Street Is Saying.
By
Bill AlpertNov. 13, 2019 1:40 pm ET
Order Reprints
Print Article
Tilray’s latest quarterly results changed no broker’s disposition toward its stock but many analysts lowered their price targets for the Canadian cannabis firm’s shares, as Wall Street published research Wednesday morning.
After Tilray (ticker: TLRY) reported on its September quarter
MAGAZINE
DATA
MORE
ABOUT
DOW JONES NETWORK
SEE ALL COMPANIESSearch
Tilray Inc. Cl 2TLRYU.S.: Nasdaq
QUOTE
COMPANY & PEOPLE
FINANCIALS
RESEARCH & RATINGS
ADVANCED CHART
BEFORE HOURS
$19.98
0.00 (0%)
PRE-MARKET VOL 2
Nov 19, 2019 4:00 p.m. ET ESTComprehensive quote
AT CLOSE
$19.98
0.07 (0.352%)
Nov 19, 2019 4:00 p.m. ET EST
Volume 1.9M
Avg Vol (65d) 1.7M
Open $19.72
Day Range $19.72 - $20.70
52 Wk Range $19.41 - $120.40
Market Value $2B
Ytd net Change -71.7%
1 Yr net Change -81.7%
EPS(TTM) $-1.38
Div & Yield N/A (N/A)
Beta 1.23
1Y
COMPARE
Jan '19Apr '19Jul '19Oct '19
Nov 27US:TLRY$114.0000
$0$100$200
DAY LOW 19.7220.70 DAY HIGH
OPEN 19.72CLOSE 19.98
NEWS
BARRON'S
OTHER DOW JONES
PRESS RELEASES
Nov 15, 2019Aurora Cannabis Stock Drops on Disappointing Results
No comments:
Post a Comment